biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > What's Your price?

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on Aug 21, 2023 9:20pm

137 Views

Post# 35599091

RE:RE:RE:What's Your price?

Boomskid wrote: Oh, don't you worry your cute little brain about my suspicions, TT.

I have a lot more to say.

Gird your loins, Dionysus.

jd

I have a lot more to say

Im sure you do/ will. Just like the past 12 years.

What became of that Johnny boy?

All that you said?

You went bankrupt??

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity